AMSBIO has added new experimental cell lines to its CAR T cell research range. Recent FDA approval of CAR T cells for treatment of leukemia and lymphoma has resulted in rapid growth in research on the therapeutic uses of such cells. The new AMSBIO experimental cell lines provide you with the power to screen antibodies and ligands […]
New rocking motion single-use bioreactor system to culture cell products in working volumes up to 5 L Flexsafe® RM TX bags enable reliable process performance for optimal cell growth Premiers at Phacilitate Leaders World 2019 in Miami Goettingen, Germany — Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry today announced the launch of the BIOSTAT® […]
Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes Service expansion parallels requirements of immunology-based research in drug discovery Cambridge, UK, 21 January, 2019: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its […]
Portfolio Expansion Lets Researchers Make Confident Decisions About Drug Discovery, Faster State College, PA – INDIGO Biosciences, Inc. (INDIGO), a leading provider of nuclear receptor and in vitro toxicology solutions, announced the release of a new hepatotoxicity assay kit. The new kit for in vitro screening of drug-induced hepatotoxicity utilizes upcyte®hepatocytes and represents another expansion of INDIGO’s growing in vitro toxicology […]
PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System Cambridge and Farnborough, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leader in the industry for the design and manufacture of automated laboratory equipment, will […]
LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), announced it has signed a distribution agreement with OLS OMNI Life Science GmbH & Co KG, a leading manufacturer and distributor of cell culture and cell assay systems for Life Science research and drug development, to distribute OLS’ CERO benchtop 3D incubator and […]
NEWS – Bournemouth, UK: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This agreement creates the most efficient cell line development solution for biotherapeutic drug developers yet, by integrating Solentim’s VIPS™ (verified in-situ plate seeding) hardware for isolating single cells with ATUM’s efficient Leap-In Transposase®expression technology. […]
Fourth generation latent TB blood test provides flexible workflow and novel CD8 technology for a more complete picture of patients’ immune response to tuberculosis infection Germantown, Maryland and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Health Canada regulatory approval of QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic […]
Visikol has announced that they will be partnering with Biopredic to launch liver 3D cell culture models for use in Visikol’s 3D cell culture assay services which leverage Biopredic’s HepaRG cells. WHITEHOUSE, N.J. A major goal for pharmaceutical companies has always been to improve the translational gap between inexpensive in vitro studies and significantly more […]
NEWS – Bournemouth, UK: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce the appointment of Claire Richards as their new Head of Biological Science. Claire Richards began her career at the Wellcome Trust Sanger Institute/Cambridge University where she did her PhD in the Cancer Genome Project Group. Shortly after […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
